1. Home
  2. ALDX vs FTLF Comparison

ALDX vs FTLF Comparison

Compare ALDX & FTLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • FTLF
  • Stock Information
  • Founded
  • ALDX 2004
  • FTLF 2005
  • Country
  • ALDX United States
  • FTLF United States
  • Employees
  • ALDX N/A
  • FTLF N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • FTLF Medicinal Chemicals and Botanical Products
  • Sector
  • ALDX Health Care
  • FTLF Health Care
  • Exchange
  • ALDX Nasdaq
  • FTLF Nasdaq
  • Market Cap
  • ALDX 160.8M
  • FTLF 149.3M
  • IPO Year
  • ALDX 2014
  • FTLF N/A
  • Fundamental
  • Price
  • ALDX $3.05
  • FTLF $13.32
  • Analyst Decision
  • ALDX Strong Buy
  • FTLF Strong Buy
  • Analyst Count
  • ALDX 2
  • FTLF 2
  • Target Price
  • ALDX $9.50
  • FTLF $20.50
  • AVG Volume (30 Days)
  • ALDX 769.8K
  • FTLF 9.6K
  • Earning Date
  • ALDX 07-31-2025
  • FTLF 08-13-2025
  • Dividend Yield
  • ALDX N/A
  • FTLF N/A
  • EPS Growth
  • ALDX N/A
  • FTLF 22.19
  • EPS
  • ALDX N/A
  • FTLF 0.90
  • Revenue
  • ALDX N/A
  • FTLF $63,856,000.00
  • Revenue This Year
  • ALDX N/A
  • FTLF $4.72
  • Revenue Next Year
  • ALDX N/A
  • FTLF $6.61
  • P/E Ratio
  • ALDX N/A
  • FTLF $15.14
  • Revenue Growth
  • ALDX N/A
  • FTLF 9.13
  • 52 Week Low
  • ALDX $1.14
  • FTLF $9.83
  • 52 Week High
  • ALDX $7.20
  • FTLF $17.75
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 61.89
  • FTLF 39.95
  • Support Level
  • ALDX $2.60
  • FTLF $13.66
  • Resistance Level
  • ALDX $3.24
  • FTLF $14.54
  • Average True Range (ATR)
  • ALDX 0.22
  • FTLF 0.59
  • MACD
  • ALDX 0.09
  • FTLF -0.12
  • Stochastic Oscillator
  • ALDX 80.93
  • FTLF 3.35

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

About FTLF FitLife Brands Inc.

FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori, and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.

Share on Social Networks: